Should you spend months or years doing product or market research, finalizing your design and eliminating every glitch?
COLUMN: Target your market to gain customers
COLUMN: 'Lean startup' is cutting-edge buzzword
No, not if you follow the lean start-up method Eric Ries advocates in his best-selling book, The Lean Startup: How Today's Entrepreneurs Use Continuous Innovation to Create Radically Successful Businesses. (Crown Business, 2011, $26).
The lean start-up has been a hot trend in entrepreneurial circles for a few years. But is it right for most small businesses?
In a nutshell, the lean start-up approach advocates launching a product or service as quickly as possible, seeing how real customers use the product then continually revising.
Top 5 Financial Stocks To Buy Right Now: Cencosud SA (CNCO)
Cencosud SA (Cencosud) is a Chile-based holding company primarily engaged in the retail sector. The Company�� activities include the management and operation of a network of supermarkets, home centers, department stores and shopping malls, which operate under such names as Jumbo, Disco & Vea, Santa Isabel, Easy, Paris, Blaisten and GBarbosa, among others. The Company�� business also comprises the provision of consumer financial services and insurance brokerage, as well as it operates family entertainment centers and a travel agency. Through its subsidiaries and affiliates, the Company has operations established in Argentina, Brazil, Chile, Colombia and Peru. As of December 31, 2010, the Company was a 25.74%-owned affiliate of Inversiones Quinchamali Limitada.
Advisors' Opinion:- [By Will Ashworth]
In terms of growth, Asia is where the company is achieving its greatest success. Operating joint ventures in China, India and Japan, Aegon’s gross deposits in new markets grew 31% in fiscal 2013 to $19.8 billion. Its underlying earnings before tax have grown 28% over the last two fiscal years, with fee-based earnings representing a much bigger part of its business than in the past. That�� a good thing, because fee-based earnings don�� have nearly the same bite if things go south than assets on your own balance sheet. Its operations outside of Europe are getting stronger, providing the diversification necessary to survive financial hiccups. As far as insurers go, AEG is one of the best cheap stocks worth owning.
Cheap Stocks to Buy: Cencosud S.A. (CNCO)Cencosud is one of the largest retailers in Latin America. It operates grocery stores, home improvement stores and department stores in five countries including Chile, its home base. Its stock is down 51% over the past year for several reasons, including a deal falling through that would have seen it sell 51% of its credit card operations in Chile and Argentina to Itau Unibanco (ITUB) and using the proceeds to reduce its heavy debt load. Add to that a major devaluation of the peso in Argentina, where it generates a quarter of its overall revenue, and you have investors in a full-on panic.
Top 10 Prefered Stocks To Buy Right Now: Twin Butte Energy Ltd (TBTEF.PK)
Twin Butte Energy Ltd. (Twin Butte) is a Canada-based junior oil and gas exploration and production company. The Company is engaged in the acquisition of, exploration for and the development and production of petroleum and natural gas properties in Western Canada. During the year ended December 31, 2011, it drilled a total of 125 (80.9 net) wells. Its Frog Lake property is located approximately 75 kilometers northwest of Lloydminster with lands. Its Freemont area is located 60 kilometers southeast of Lloydminster. During 2011, Twin Butte drilled 11 gross wells in Plains region. Production from its west central Alberta region was approximately 1,545 barrels of oil equivalent per day during 2011. Production from its Deep Basin region was approximately 593 barrels of oil equivalent per day during 2011. Effective September 30, 2013, the Company disposed a non-core, west central Alberta, gas asset. In November 2013, the Company acquired Black Shire Energy Inc. Advisors' Opinion:- [By MLP Trader]
Here are the current top five companies in the list:
CompanySymbolEV/BOEPD/NetbackPrice/NAVEV/DACFPinecrest(PNCGF.PK)53564%4.0XLightstream(LSTMF.PK)131753%4.5XNovus(NOVUF.PK)133290%4.1XZargon(ZARFF.PK)138664%5.6XTwin Butte(TBTEF.PK)155885%5.5XOf the larger companies, one that remains obstinately near the top of the list is Lightstream . Lightstream trades at 40% of its book value and a whopping 13.4% yield.
Top 10 Prefered Stocks To Buy Right Now: Powerdyne International Inc (PWDY)
Powerdyne International, Inc., formerly Greenmark Acquisition Corporation, incorporated on September 13, 2006, is a development-stage company. The Company focuses on manufacturing, installing, maintaining, owning and operating portable electrical power generation equipment (gensets).
The Company's initial product is the PDIGenset, which is a self contained generator that is powered by a modified radial air cooled engine to drive a minimum of a 1-megawatt generator. The entire unit, which runs on natural gas or propane, is compact, lightweight and clean burning. The Company also focuses on the process of building its first prototype of the PDIGenset. As of December 31, 2010, the Company had not generated any revenues.
The Company competes with Caterpillar Corporation, Cummings, Morse Diesel, Kohler, Volvo and Detroit Diesel.
Advisors' Opinion:- [By Peter Graham]
On Friday, small cap stocks EHouse Global (OTCBB: EHOS), Sanwire Corporation (OTCMKTS: SNWR) and Powerdyne International Inc (OTCBB: PWDY) sank 37.38%, 29.47% and 23.23%, respectively, despite some evidence of paid stock promotions or investor relation campaigns. Of course, volatility is a given for small cap OTC stocks, but paid stock promotions or investor relations campaigns tend to add to that volatility. With that in mind, what will these three small cap stocks do for investors this holiday trading week? Here is a closer look to help you decide on a trading or investment strategy:
Top 10 Prefered Stocks To Buy Right Now: Puma Biotechnology Inc (PBYI)
Puma Biotechnology, Inc., incorporated in April 2007, is a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. As of December 31, 2011, the Company licensed three drug candidates: PB272 (neratinib (oral)), which the Company is developing for the treatment of advanced breasts cancer patients and gastric cancer patients; PB272 (neratinib (intravenous)), which the Company is developing for the treatment of advanced cancer patients, and PB357.
PB272 (neratinib (oral))-Breast Cancer
Neratinib is a potent irreversible tyrosine kinase inhibitor, or TKI, that blocks signal transduction through the epidermal growth factor receptors (EGFRs), HER1, HER2 and HER4. The Company's initial focus is on the development of neratinib as an oral treatment of patients with HER2 positive metastatic breast cancer.
PB272 (neratinib (intravenous))
The Company develops neratinib as an intravenously administered agent. In pre-clinical studies the intravenous version of neratinib resulted in higher exposure levels of neratinib in pre-clinical models.
PB357
PB357 is an orally administered agent that is an irreversible TKI that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. PB357 is structurally similar to PB272. Pfizer completed single dose Phase I trials of PB357. The Company is evaluating PB357.
The Company competes with Genentech, GlaxoSmithKline, Roche, Boehringer Ingelheim, Takeda, Array Biopharma and Ambit Biosciences.
Advisors' Opinion:- [By George Budwell]
With that being said, developmental biotechs that fall hard on news could be worth taking a look at because they may have fallen for all the wrong reasons. Puma Biotechnology (NYSE: PBYI ) , for example, plummeted by 25% about a month ago after reporting mid-stage clinical trial data for the company's flagship cancer drug PB272 (neratinib).
- [By John Udovich]
Yesterday, small cap biopharmaceutical stock Puma Biotechnology Inc (NYSE: PBYI) jumped 11.98% after announcing they will have a conference call next week to update�investors on�its clinical trials of PB272 (neratinib) in cancer patients, meaning its probably time to take a closer look at the stock to see if investor might be counting the chickens before they hatch along with the performance of large cap AbbVie Inc (NYSE: ABBV) which also recently had positive news about its own breast cancer treatment plus biotech ETFs iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
Top 10 Prefered Stocks To Buy Right Now: Stage Stores Inc.(SSI)
Stage Stores, Inc. operates as a specialty department store retailer that offers branded and private label apparel, accessories, cosmetics, and footwear for women, men, and children in the United States. The company also offers sportswear, dresses, intimates, home and gift products, outerwear, swimwear, and other products. It primarily focuses on consumers in small and mid-sized markets. The company operates stores under the names of Bealls, Goody?s, Palais Royal, Peebles, and Stage. Stage Stores, Inc. also sells its products through its Web site. As of March 06, 2012, it operated 819 stores in 40 states. Stage Stores, Inc. is headquartered in Houston, Texas.
Advisors' Opinion:- [By Anna Prior]
Stage Stores Inc.(SSI) said it agreed to sell its Steele’s retail stores to financial services firm Hilco Global later this year, which contributed to a drop in fiscal fourth-quarter earnings. The top line missed expectations, and the sales view for the year also fell below the consensus view.
Top 10 Prefered Stocks To Buy Right Now: GTT Communications Inc (GTT)
GTT Communications, Inc., formerly Global Telecom & Technology, Inc., incorporated on January 3, 2005, is a global network integrator providing a portfolio of Wide-Area Network (WAN), dedicated Internet access and managed data services. The Company combines multiple networks and technologies, such as traditional OC-x, MPLS and Ethernet, to deliver solutions designed for each client�� requirements. The Company improves its client performance through its Client Management Database (CMD), providing customers with an integrated support system for all of their services. It is provides solutions, project management and 24x7 global operations support. In May 2012, the Company acquired nLayer Communications Inc. In April 2013, Neutral Tandem Inc acquired the global data services business of Global Telecom & Technology Inc.
The Company�� global operations consist of two parts: global customer operations, and global network operations and engineering. Customer operations include project management and development of its CMD system. Global project management assures the implementation of a customer services after the sale. Network operations and engineering consists of global Network Operations Center (NOC) and Engineering and Information and Communications Technology (ICT). The NOC receives, prioritizes, tracks and resolves network outages or other customer needs, along with provisioning and testing of services. Engineering provides support for the NOC and the sales team, as well as carrying out all provisioning for GTT Network Services. ICT manages all internal desktop, and network and server infrastructure.
The Company competes with Level 3, Qwest, KPN, XO Communications, COLT, Verizon Business, AT&T, British Telecom, NTT and Deutsche Telekom.
Advisors' Opinion:- [By The GeoTeam]
This brings us to Global Telecom (GTT), a company that provides customers with innovative connectivity solutions by utilizing its own network assets.
Top 10 Prefered Stocks To Buy Right Now: MWI Veterinary Supply Inc.(MWIV)
MWI Veterinary Supply, Inc., together with its subsidiaries, engages in the distribution of animal health products to veterinarians in the United States and the United Kingdom. It primarily offers pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, specialty products, veterinary pet food, and nutritional products. The company?s pharmaceutical products include anesthetics, analgesics, antibiotics, ophthalmics, and hormones; vaccine products consist of small animal, equine, and production animal biologicals; and parasiticides are used for control of fleas, ticks, flies, mosquitoes, and internal parasites. Its diagnostics products comprise consumable in-clinic tests for detecting heartworm, lyme, feline leukemia, and parvovirus, as well as consumable products for measuring blood chemistry, electrolyte balance, and cell counts; capital equipment products include anesthesia machines, surgical monitors, diagnostic equipment, dental machines, cage s, lights, and x-ray machines; and supplies consists of syringes, instruments, bandages, IV products, surgical consumables, grooming materials, and other small equipment items. The company?s veterinary pet foods products include foods for specialty diets and premium pet foods; and nutritional products comprise dietary supplements, vitamins, dental chews, and specialty treats. As of September 30, 2011, it served approximately 24,000 veterinary practices in the United States; and 1,500 veterinary practices in the United Kingdom. The company was formerly known as MWI Holdings, Inc. and changed its name to MWI Veterinary Supply, Inc. in April 2005. MWI Veterinary Supply, Inc. was founded in 1976 and is headquartered in Boise, Idaho.
Advisors' Opinion:- [By Rupert Hargreaves]
Pet-related companies are highly sought after
Having said that, it would appear that in comparison to the rest of the pet-related sector, Zoetis is fairly valued. Peer MWI Veterinary Supply (NASDAQ: MWIV ) trades at 27 times forward earnings, and again the company is highly defensive, engaging in the distribution of animal health products to veterinarians in the United States and the United Kingdom. Veterinary supply is exposed to the same demand factors as Zoetis -- greater demand for animal treatments will lead to more demand for the distribution of animal health products. - [By Ben Levisohn]
Overvalued companies include MWI Veterinary (MWIV) and�Stericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but calls�Aratana (PETX) a “hidden gem.”
No comments:
Post a Comment